NCT04926662

Brief Summary

The purpose of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
36mo left

Started Jul 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Jul 2021Jun 2029

First Submitted

Initial submission to the registry

June 10, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 15, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

July 14, 2021

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2029

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

7.5 years

First QC Date

June 10, 2021

Last Update Submit

August 18, 2025

Conditions

Lung Cancer

Outcome Measures

Primary Outcomes (1)

  • Recruitment

    Number of individuals recruited to the mobile lung cancer screening units

    6 months after starting the mobile lung cancer screening units (Aim 3)

Secondary Outcomes (1)

  • Change in knowledge

    6 months after starting the mobile lung cancer screening units (Aim 3)

Study Arms (3)

Aim 1: Focus Groups

Focus groups will be conducted in 2 New Hampshire and 2 Vermont towns to better understand patient knowledge, attitudes, and preferences regarding access to lung cancer screening.

Aim 2: Cross Sectional Survey

Based on focus group feedback, the investigators will visit each proposed site to survey on 2 separate dates to confirm days and times of high traffic. The investigators will also survey patrons at the proposed locations to further determine prospective patient mobile screening preferences and evaluate willingness to participate in screening.

Aim 3: Survey with follow up data

The investigators will pilot mobile lung cancer screening clinics at each chosen location using the knowledge acquired from focus group experience and local patient survey. Surveys will be conducted at these clinics, and patients will be followed for up to 5 years.

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The individuals that will be included in this study will be those that meet lung cancer screening eligibility.

You may qualify if:

  • Adults age 50 to 80 years old
  • pack-year smoking history who are currently smoking or have quit smoking within the last 15 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03755, United States

Location

Related Publications (6)

  • Odahowski CL, Zahnd WE, Eberth JM. Challenges and Opportunities for Lung Cancer Screening in Rural America. J Am Coll Radiol. 2019 Apr;16(4 Pt B):590-595. doi: 10.1016/j.jacr.2019.01.001.

    PMID: 30947892BACKGROUND

  • Brenner AT, Malo TL, Margolis M, Elston Lafata J, James S, Vu MB, Reuland DS. Evaluating Shared Decision Making for Lung Cancer Screening. JAMA Intern Med. 2018 Oct 1;178(10):1311-1316. doi: 10.1001/jamainternmed.2018.3054.

    PMID: 30105393BACKGROUND

  • Atkins GT, Kim T, Munson J. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival. Ann Am Thorac Soc. 2017 Mar;14(3):403-411. doi: 10.1513/AnnalsATS.201606-469OC.

    PMID: 28118039BACKGROUND

  • Greenwald ZR, El-Zein M, Bouten S, Ensha H, Vazquez FL, Franco EL. Mobile Screening Units for the Early Detection of Cancer: A Systematic Review. Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1679-1694. doi: 10.1158/1055-9965.EPI-17-0454. Epub 2017 Oct 4.

    PMID: 28978564BACKGROUND

  • Bhatt S, Isaac R, Finkel M, Evans J, Grant L, Paul B, Weller D. Mobile technology and cancer screening: Lessons from rural India. J Glob Health. 2018 Dec;8(2):020421. doi: 10.7189/jogh.08.020421.

    PMID: 30603075BACKGROUND

  • Vang S, Margolies LR, Jandorf L. Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review. Prev Chronic Dis. 2018 Nov 15;15:E140. doi: 10.5888/pcd15.180291.

    PMID: 30447104BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • David Finley, MD

    Dartmouth-Hitchcock Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician, Thoracic Surgery

Study Record Dates

First Submitted

June 10, 2021

First Posted

June 15, 2021

Study Start

July 14, 2021

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

June 1, 2029

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations

US(1)